158276-23-4 Usage
Uses
Used in Pharmaceutical Industry:
H-LYS(NICOTINOYL)-OH HCL is used as a pharmaceutical intermediate for the development of drugs targeting various health conditions. H-LYS(NICOTINOYL)-OH HCL's unique structure, combining lysine with a nicotinoyl group, may offer novel therapeutic effects and properties.
Used in Cosmetics Industry:
In the cosmetics industry, H-LYS(NICOTINOYL)-OH HCL is used as an active ingredient for skincare products. Its potential role in metabolic processes and protein synthesis may contribute to skin health and rejuvenation.
Used in Research Applications:
H-LYS(NICOTINOYL)-OH HCL is utilized as a research tool in biological and chemical studies. Its unique properties allow scientists to explore its effects on cellular processes, protein interactions, and potential therapeutic applications.
Used in Nutritional Supplements:
As a nutritional supplement, H-LYS(NICOTINOYL)-OH HCL may be used to support protein synthesis and overall health. Its enhanced solubility and stability make it a practical option for supplement formulations.
Used in Food and Beverage Industry:
In the food and beverage industry, H-LYS(NICOTINOYL)-OH HCL could be employed as a functional ingredient to enhance the nutritional profile of products, potentially contributing to health benefits related to protein synthesis and metabolic processes.
Check Digit Verification of cas no
The CAS Registry Mumber 158276-23-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,8,2,7 and 6 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 158276-23:
(8*1)+(7*5)+(6*8)+(5*2)+(4*7)+(3*6)+(2*2)+(1*3)=154
154 % 10 = 4
So 158276-23-4 is a valid CAS Registry Number.
158276-23-4Relevant academic research and scientific papers
Janecka, Anna,Janecki, Tomasz,Shan, Si-mei,Bowers, Cyril,Folkers, Karl
, p. 2238 - 2241 (1994)
A series of luteinizing hormone-releasing hormone antagonists with new substitutions in position 6 or positions 5 and 6 that included lysine acylated at the ε-amino group with different heterocyclic carboxylic acids or amino-substituted heterocyclic carboxylic acids was synthesized.These novel analogs were synthesized on a solid-phase support via the acylation of lysine residue in otherwise protected resin-bound peptides.All analogs were tested in the rat antiovulatory assay (AOA) and the best of them in in vitro histamine release assay.Introduction of lusine acylated with amino-substituted heterocyclic carboxylic acids yielded several water-soluble antagonists with good therapeutic ratio (high AOA to low histamine releasing activity).The best antagonist in terms of activity, histamine release, and solubility was nictide: NAcDNal-DCpa-DPal-Ser-PicLys-D(6ANic)-Orn-Leu-ILys-Pro-DAlaNH2 (6ANic = 6-aminonicotinoyl).
